NM_015884.4:c.119A>C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_015884.4(MBTPS2):c.119A>C(p.Asn40Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,208,706 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_015884.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MBTPS2 | ENST00000379484.10 | c.119A>C | p.Asn40Thr | missense_variant | Exon 2 of 11 | 1 | NM_015884.4 | ENSP00000368798.5 | ||
MBTPS2 | ENST00000365779.2 | c.119A>C | p.Asn40Thr | missense_variant | Exon 2 of 7 | 1 | ENSP00000368796.1 | |||
MBTPS2 | ENST00000465888.1 | n.218A>C | non_coding_transcript_exon_variant | Exon 2 of 6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000178 AC: 2AN: 112188Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34340
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183511Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67941
GnomAD4 exome AF: 0.0000146 AC: 16AN: 1096518Hom.: 0 Cov.: 29 AF XY: 0.0000166 AC XY: 6AN XY: 361898
GnomAD4 genome AF: 0.0000178 AC: 2AN: 112188Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34340
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.119A>C (p.N40T) alteration is located in exon 2 (coding exon 2) of the MBTPS2 gene. This alteration results from a A to C substitution at nucleotide position 119, causing the asparagine (N) at amino acid position 40 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
IFAP syndrome 1, with or without BRESHECK syndrome Uncertain:1
This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PP2,BP4. This variant was detected in hemizygous state. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at